skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi team,

I don't see any questions on this company Cardiol Therapeutics Inc. (CRDL) that did a recent IPO on TSX and hit a 52 week high today. It seems they are in a (speculative) cannabinoid arena with some drugs coming into phase 1 stages in 2019.
What is management history (CEO, CFO, etc.), board of directors, ...ie are they a solid team?
They had a string of announcements (LOI's, exclusive agreements, etc) in 2017 but no real follow-up news in 2018 wrt these signings.
Does their product pipeline seem promising?
How might it compare to Cannimed wrt therapeutic applications?

Is it a company to just watch for now given it's very recent IPO? So many IPO's flop in the first 6 months thus the caution.

Appreciate your insight!

Cheers,
SteveMc
Read Answer Asked by Stephen on February 06, 2019
Q: Greetings 5i crew,
If one were interested in investing in the graphene industry where would you suggest we park some capital to do so?
One company came on my radar called Graphene Nanochem symbol GRPEF. Unfortunately cannot find enough information on it to make an educated decision upon. Any info would be much appreciated. http://www.graphenenanochem.com/

Cheers
Stew
Read Answer Asked by Alex on February 05, 2019
Q: The company sold roughly 50% of it's stake in Peanuts for over $300,0000,000 cdn . That mean it still has an asset worth 300,000,000 at the very least. That works out to a value of $3/share just for the Peanuts asset. Can you tell me where in the Assets category of their balance sheet that this asset would be included in? Is it intangibles or library content or something else? Thanks.
Read Answer Asked by Murray on February 04, 2019